FR940504-2-00077 FR940504-2-00067 Manufacturer of Controlled Substances; Application Pursuant to §1301.43(a) of Title 21 of the Code of Federal Regulations (CFR), this is notice that on March 15, 1994, Penick Corporation, 158 Mount Olivet Avenue, Newark, New Jersey 07114, made application to the Drug Enforcement Administration (DEA) for registration as a bulk manufacturer of the basic classes of controlled substances listed below: ␣ 1Drug 1Schedule Tetrahydrocannabinols (7370) I Dihydromorphine (9145) I Pholcodine (9314) I Alphacetylmethadol (9603) I Cocaine (9041) II Codeine (9050) II Dihydrocodeine (9120) II Oxycodone (9143) II Hydromorphone (9150) II Diphenoxylate (9170) II Benzoylecgonine (9180) II Ethylmorphine (9190) II Hydrocodone (9193) II Merperidine (9230) II Methadone (9250) II Methadone-intermediate (9254) II Dextropropoxyphene, bulk (non-dosage forms) (9273) II Morphine (9300) II Thebaine (9333) II Opium extracts (9610) II Opium fluid extract (9620) II Opium tincture (9630) II Opium powdered (9639) II Opium granulated (9640) II Oxymorphone (9652) II Phenazocine (9715) II Alfentanil (9737) II Sufentanil (9740) II Fentanyl (9801) II Any other such applicant and any person who is presently registered with DEA to manufacture such substances may file comments or objections to the issuance of the above application and may also file a written request for a hearing thereon in accordance with 21 CFR 1301.54 and in the form prescribed by 21 CFR 1316.47. Any such comments, objections, or requests for a hearing may be addressed to the Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration, United States Department of Justice, Washington, DC 20537, Attention: DEA Federal Register Representative (CCR), and must be filed no later than June 3, 1994. Dated: April 25, 1994. Gene R. Haislip, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. 94&hyph;10680 Filed 5&hyph;3&hyph;94; 8:45 am] BILLING CODE 4410&hyph;09&hyph;M
